Our blog includes news from LINQ, information about recent events in the projects we work with, and insights into the markets and funding programmes relevant to our projects.
New project: PROTECT builds capacity for maternal vaccine trials
We’re happy to announce the launch of PROTECT, a new EU-funded initiative that aims to strengthen maternal vaccine trial capacity in Kenya, Malawi, Mozambique, and Uganda.
One year into the project, the GenPath Africa consortium came together at the Biomedical Research Institute (BMRI) in Cape Town, South Africa, for its first in-person meeting on May 27-28, 2024.
New EU project to tackle parasitic worm infections
On 24 and 25 October 2023 the WORMVACs2.0 consortium kicked-off a new 5-year EU-funded project that aims to develop vaccines against schistosome and hookworm infections.
From 02 - 04 October the TB-CAPT consortium convened for a face-to-face progress meeting in Dar-es-Salaam, Tanzania, hosted by our local project partners from Ifakara Health Institute.
Next-generation vaccines against GI mucosal pathogens
Our new project Vax2Muc sets out to develop improved, innovative, next generation subunit vaccines against diseases caused by AMR mucosal pathogens that colonise the GI tract.
New Project: MARC SE-Africa tackles malaria drug resistance
We are delighted to add the GH EDCTP3 JU-funded MARC SE-Africa project to our portfolio, coordinated by Professor Karen I. Barnes of the University of Cape Town in South Africa.
On October 5-6, the StatinTB consortium, led by Prof Reto Guler of the University of Cape Town, convened for the StatinTB year four progress meeting in Cape Town, South Africa
On June 9, the EDCTP-part of the PredictTB consortium held its final meeting online. The 5.5-year project is scheduled to draw to a close at the end of July this year.
